Abstract-The purpose of this discussion was to prepare and appraise invivo and invitro effect of the spray-dried Amphotericin B (AmB) -loaded nanospheres. The spraydried nanospheres were prepared by using aerosol and Am.B entrapment effect was measured by HPLC method. Minimum inhibitory concentration (MIC) of AmB-loaded nanospheres against Candida albicans (ATCC 90028) was defined by using micro dilution method and its in vitro haemolytic effect and antifungal effect on infected rabbits was also analyzed. The MIC of Am.B-loaded nanospheres against C. albicans compared to the free antibiotic was lower significantly. Invivo testing indicated that AmBloaded nanospheres have a stronger protective effect against candidiasis compared to the free AmB. Results of this discussion indicate that prepared spray-dried Am.B-loaded nanospheres would be a good choice for the therapy of mycosis because of low toxicity and high consistency and effect. By developing this method can greatly reduce the side effects of antibiotics in human body.
I. INTRODUCTION
Amphotericin B by binding to ergosterol in the fungal cell membrane creates a membrane channel that motivation leads to leakage of ions across the membrane of the single valence. Amphotericin B is an appropriate drug for the therapy of mycosis [1] . But, this antibiotic has low aqeous solibility and is poorly absorbed in digestion tract which confine its uses for the therapy of systemic fungal infections [2] , [3] . Various types of drug formulations for AmB such as micellar solution of AmB with deoxycholate having serious nephrotoxicity and lipid-based nanoparticulate formulations of low nephrotoxicity have been investigated [4] , [5] . Moreover these formulations are quite expensive. In this field polymeric nanoparticle rendition systems has been ediwinvestigated [6] , [7] . Nanoparticles, as a polymeric sub-micron carriers have a general name to describe nanocapsules and nanospheres [8] . According to the literature, the nanospheres have a polymeric wall envelope and an oil core matrix [9] . Nanosphere suspensions have been developed as drug targeting delivery system, using polyesters, poly (alklylcyanoacrylate), poly and other polymers [10] , [11] . The development of these systems for industrial aims are limited due to low maintaining stability of suspensions for a prolonged time period and usually, prepared nanoparticles tend to sum because nanoparticles sediment slowly and separated by severe mixing [12] , [13] . But, agglomeration of nanoparticles in suspension can occur [5] . Spray-drying has been shown as a well method for drying of nanoparticles and to increase the stability of drug-loaded nanoparticles [7] , [12] . The aim of the present study was to apply the spray-dried technique for drying of the prepared AmB-loaded nanospheres using poly-lactid -glycoli ( AGLA ) i assessment of the consistency and in vitro hemolytic effect and invivo therapeutic efficacy of the collected nanoparticles. By developing this method can greatly reduce the side effects of antibiotics in human body while antibiotic resistant microbes reduce the human body can be prevented to some extent.
II. MATERIAL AND METHODS
Poly lactic-co-glycolic acid (Capped, alkylester terminated, M.W.: 76000-115000 and Ratio of lactid to glycolid of 75:25), sorbitan monostearate, RPMI 1640 and AmB were obtained from Sigma (USA). Colloidal silicon dioxide (aerosil 200) was purchased from Degussa (Germany).
A. Ministration of the Spray-Dried Amb-Loaded
Nanospheres Samples were prepared by nanoprecipitation of PLGA by the reported method [14] . Briefly, the AmB-loaded nanosphers suspension was prepared by dissolving the PLGA (l g), AmB (0.150 g) and the sorbitan monostearate (0.766 g) in acetone (270 ml) and polysorbate 80 (0.766 g). Then, the prepared suspension was spray-dried by the reported method [12] . Moreover, aerosil 200 [3.0% (w/v)] was added to the nanospheres suspension and the mixture was fed into a mini-spraydryer Büchi MSD 190 (Flawil, Switzerland).
AmB-loaded nanospheres containing 30 µg of AmB were placed into 20 ml of the dissolution medium [1% (v/v) of Tween 80 in 10mM HEPES buffer, pH 7.4 at 37°C. Then at pre-determined time intervals of 1, 2 and 3 months eleased AmB was determined using HPLC method [8] .
The respective percentage of yield was calculated using the following equation:
of nanospher obtained 100 of yield = of Amb and polymers used wieght percentage Total wieght

For determination of entrapment efficiency, the content of AmB in loaded nanospheres was determined by HPLC as described previously [8] . Then, the amount of drug entrapped was computed as: 
B. Particle Size and Zeta-Potential Mensuration
Mean particle size and zeta-potential of the prepared nanospheres before and after drying process were evaluated by the reported method using Malvern zetasizer (Malvern instrument Ltd., Worcestershire, UK) apparatus [14] , [15] .
C. In Vivo and in Vitro Study
In vitro toxicity of the free and prepared nanospheres containing AmB was determined by the reported method [16] . Likewise, blood samples were collected from rabbits in the presence of the heparin. Then, 0.2 ml of PBS containing various amounts of free and nanosphere forms of AmB (0-400 μg AmB/ml) were mixed with 0.8 ml of 0.1% red blood cells (vol. /vol.) suspension and in vitro haemolytic effects of the dose levels of AmB was determined by spectrophotometer (model 1700, shimadzu, Japan). In vivo therapeutic efficacy of the prepared nanoparticles was tested by a described method [14] , with some modification. Forty male white rabbits (2.5-3 kg body weight) obtained from the National Institute of Pastour (Iran) were handled according to the national guidelines of the laboratory animals [17] . Animals were infected with 0.25 ml of Candida albicans cell suspension (7×10 6 cells/ml) in normal saline via the caudal vein and divided into 4 groups. All groups received the drug intravenously as follows: Group 1 received free AmB (1mg/kg); group 2 received AmB-loaded nanospheres (1 mg/kg); group 3 received empty nanospheres (1mg/kg) and group 4, received physiological saline (1ml/kg). All groups were treated as described above for 12 days starting from the 3rd day of infection. Two days after the last dose the survived rabbits were anesthetized and sacrificed. Then fungal colony forming units (CFU) in lung, liver, kidney, spleen and brain was determined. Statistical analyses all data were expressed as mean ± SE. The CFU values were statistically evaluated by analysis of variance of one-way classification with unequal frequencies from three separate experiments. The percentage of survival rabbits were determined by using Chi-squared with Yates correction and by Fisher's exact test.
D. Concentration Inhibitory Minimum
The MICs of AmB in free and nanospheres loaded forms were determined by micro dilution methodology, according to Clinical and Laboratory Standards Institute [18] . Briefly, Candida albicans (ATCC 90028) cell suspensions of ~1×10 6 cells/ml were diluted 1:50 in RPMI-1640 growth medium and dispensed (100 μl) into a micro titer tray containing serial two-fold dilutions of AmB. The tray was then incubated for 48 h at 37°C. The MIC was recorded to be the lowest concentration of the AmB in free and nanosphere forms that prevented visible growth of C. albicans and expressed in µg/ml. 
III. RESULTS AND DISCUSSION

A. Particle Size and Zeta-Potential Analysis
The results showed that percentage of yield and AmB entrapment efficiency were almost 58% and 65%, respectively. Table I, shows mean particle size and zetapotential of empty and AmB-loaded nanospheres before and after drying process. According to the previous studies, Size homogeneity of empty and AmB-loaded nanospheres which was suggested that AmB was entrapped into nanoparticle core, [4] , [6] . Also, the high negative zeta-potential of the collected nanospheres picked that the nanoparticles have suitable consistency in aqueous dispersion [14] . 
M o n t h s
B. In Vitro and In Vitro Studies
The percentage of AmB recoveries for nanospheres after 3 months was 88% ± 3 ( Fig. 1) . This phenomenon suggested that majority of AmB incorporated into nanoparticles. This conclusion is not in match with the past reports that have indicated within 5-30 minutes most of AmB were released from nanoparticles, since AmB was attached to the outer surface of the nanoparticles [3] , [14] .
The hemolytic ability of free AmB and AmB-loaded nanospheres is shown in Fig. 2 . The maximum hemolytic conclusion (100% lysis) for AmB-loaded nanospheres was estimated to be 361 μg/ml. Under all conditions, by increasing AmB doses (0-250 μg AmB/ml), the percentage of haemolytic effect increased. AmB-loaded nanospheres showed mild toxicity (1.2% lysis of erythrocytes) as compared to the free drug. Data of this study are in match with results of another report [3] .
C. Minimum Inhibitory Concentration (MIC)
The MIC of AmB-loaded nanospheres against C. albicans was decreasing 3-fold compared with free AmB. This conclusion indicates that prepared AmB-loaded nanospheres like NS-718, LNS-AmB and LNP S -AmB (lipid nanoparticles incorporated with AmB) have high therapeutic effect and are useful for the treatment of mycosis, including candidiasis [9] , [10] .
D. Therapeutic Efficacy of AmB-Loaded Nanospheres on Candidiasis Rabbit Model
The treatment of Candida albicans-infected rabbits with AmB-loaded nanospheres as compared with control animals showed significant reduction in CFU values in evaluated organs especially in kidney and spleen Table II .
It was found that mortality of Candida albicansinfected rabbits as control (without AmB administrated) was 100% after 15 days, whereas rabbits treated with free AmB and AmB-loaded nanospheres showed increment in survival rate of 20 and 90%, respectively. One of the reasons for the differences in the antifungal potencies and toxicities amongfree AmB and prepared AmB formulations could be due to high consistency of AmBloaded nanoparticles [6] . The values are expressed as mean ± SE from three separate experiments. Analysis of variance of one-way classification between the treatment means was heterogeneous and the t-test values (two-tailed) were significant, * p < 0.05 and ** p <0.001
IV. CONCLUSION
The prepared spray-dried AmB-loaded nanospheres may demonstrate a more adequate choice for treatment of mycose because efficacy and toxicity of this formulation was balanced and probably in future it may serve as an effective newfound, antifungal drug delivery system for treatment of patients with fungal infections.
